Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland

Clinical trial NCT01630226 · UNKNOWN

Trial details

NCT number: NCT01630226
Sponsor: Pomeranian Medical University Szczecin
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

BRCA1 Mutation Breast Cancer Invasive Nos

Start date: 2007-06-01
Primary completion: 2013-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.